Cellaviva is Scandinavia’s leading private biobank specializing in family stem cell preservation from the afterbirth, including umbilical cord blood, cord tissue and placenta. With full regulatory approval from the Swedish Health and Social Care Inspectorate (IVO), Cellaviva is the only biobank of its kind in Sweden. Our services are grounded in the latest scientific standards and aim to provide families with long-term health security through access to future medical treatments. In addition to stem cell banking, Cellaviva offers a growing portfolio of genetic tests and preventive health services designed to support proactive healthcare and early intervention. We work in close collaboration with healthcare providers, public authorities, and research institutions to ensure quality, safety, and ethical excellence in everything we do.
Looking for a particular Cellaviva employee's phone or email?
The Cellaviva annual revenue was $6 million in 2026.
Sofie Jansson is the Chief Executive Officer (CEO) of Cellaviva.
9 people are employed at Cellaviva.
The NAICS codes for Cellaviva are [3254, 32, 325].
The SIC codes for Cellaviva are [283, 28, 80].